Vanda Pharmaceuticals Inc (NASDAQ:VNDA)
| 15.97 Delayed Data As of Dec 01 |  -0.23 / -1.42%Today’s Change | 12.23 Today|||52-Week Range 21.86 | +21.54% Year-to-Date |
Latest VNDA News | Press Releases
No recent news for Vanda Pharmaceuticals Inc.
Today’s Trading
| Previous close | 16.20 |
| Today’s open | 16.19 |
| Day’s range | 15.73 - 16.23 |
| Volume | 47,295 |
| Average volume (3 months) | 430,434 |
| Market cap | $923.7M |
Data as of 4:00pm ET, 12/01/2021
Growth & Valuation
| Earnings growth (last year) | -80.28% |
| Earnings growth (this year) | +32.14% |
| Earnings growth (next 5 years) | +61.47% |
| Revenue growth (last year) | +9.23% |
| P/E ratio | 26.6 |
| Price/Sales | 2.92 |
| Price/Book | 2.01 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GRTSGritstone bio Inc | -1.19 | -9.02% |
| ZEALZealand Pharma A/S | -0.17 | -0.80% |
| KURAKura Oncology Inc | -0.63 | -4.51% |
| AMPHAmphastar Pharmaceut... | +0.32 | +1.64% |
Data as of 4:44pm ET, 12/01/2021
Financials
| Next reporting date | February 16, 2022 |
| EPS forecast (this quarter) | $0.09 |
| Annual revenue (last year) | $248.2M |
| Annual profit (last year) | $23.3M |
| Net profit margin | 9.40% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Washington, District Of Columbia |
Forecasts
